Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Anshen drops for insomnia
ChiCTR2500099583Phase 3Completed
- Sponsor
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Anshen granules in Insomnia (2 arms), sponsored by The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Change from baseline in total Pittsburgh Sleep Quality Index score on day 29. Started Mar 2025; status: completed.
02
Drugs
Anshen granules
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2500099583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099583.